Abstract:Therapeutic antibodies must have "drug-like" properties. These include high affinity and specificity for the intended target, biological activity, and additional characteristics now known as "developability properties": long-term stability and resistance to aggregation when in solution, thermodynamic stability to prevent unfolding, high expression yields to facilitate manufacturing, low self-interaction, among others. Sequence-based liabilities may affect one or more of these characteristics. Improving the stability and developability of a lead antibody is typically achieved by modifying its sequence, a time-consuming process that often results in reduced affinity. Here we present a new antibody library format that yields high-affinity binders with drug-like developability properties directly from initial selections, reducing the need for further engineering or affinity maturation. The innovative semi-synthetic design involves grafting natural complementarity-determining regions (CDRs) from human antibodies into scaffolds based on well-behaved clinical antibodies. HCDR3s were amplified directly from B cells, while the remaining CDRs, from which all sequence liabilities had been purged, were replicated from a large next-generation sequencing dataset. By combining two in vitro display techniques, phage and yeast display, we were able to routinely recover a large number of unique, highly developable antibodies against clinically relevant targets with affinities in the subnanomolar to low nanomolar range. We anticipate that the designs and approaches presented here will accelerate the drug development process by reducing the failure rate of leads due to poor antibody affinities and developability.Abbreviations: AC-SINS: affinity-capture self-interaction nanoparticle spectroscopy; CDR: complementarity-determining region; CQA: critical quality attribute; ELISA: enzyme-linked immunoassay; FACS: fluorescence-activated cell sorting; Fv: fragment variable; GM-CSF: granulocyte-macrophage colony-stimulating factor; HCDR3: heavy chain CDR3; IFN2a: interferon α-2; IL6: interleukin-6; MACS: magnetic-activated cell sorting; NGS: next generation sequencing; PCR: polymerase chain reaction; SEC: size-exclusion chromatography; SPR: surface plasmon resonance; TGFβ-R2: transforming growth factor β-R2; VH: variable heavy; VK: variable kappa; VL: variable light; Vl: variable lambda.

Approach for Construction of a Completely Synthetic Human Antibody Library from Well-expressed Framework

Construction of a fully synthetic human scFv antibody library with CDR3 regions randomized by a split-mix-split method and its application.

Construction and Optimization of Human Combinatorial Antibody Libraries

Development of novel humanized VHH synthetic libraries based on physicochemical analyses

Construction of a human scFv antibody library with VH regions randomized and its application

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

A Method for Constructing Reshaping Single-Domain Antibody

Construction of a Large Naive Human Single Chain Fv(scFv) Library for Ribosome Display

Sequence‐based design and construction of synthetic nanobody library

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

A single-domain antibody library based on a stability-engineered human VH3 scaffold

Construction of Expression Vectors and Study on Single-Chain Antibody and Reshaping Single-Domain Antibody Against CD3

A Single-Chain Antibody Using LoxP511 as the Linker Enables Large-Content Phage Library Construction via Cre/LoxP Recombination

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Construction of Synthetic Nanobody Library in Mammalian Cells by Dsdna-Based Strategies*.

Semisynthetic Phage Display Library Construction: Design and Synthesis of Diversified Single-Chain Variable Fragments and Generation of Primary Libraries

The process using a synthetic library that generates multiple diverse human single domain antibodies

Construction and preliminary application of a human natural phage antibody library with diversity]

Semisynthetic Phage Display Library Construction: Generation of Single-Chain Variable Fragment Secondary Libraries

Construction and validation of a synthetic phage-displayed nanobody library

Construction and preliminary identification of a large Nayve human antibody library